Newsletter

Jail Pharm, smoking cessation treatment Varenicline NicoChamps high growth

Jail Pharmaceutical announced on the 11th that its smoking cessation aid treatment ‘Nico Champs (Varenicline)’ exceeded 10 billion won in cumulative domestic sales in two years after its launch.

Nico Champs 2 product photos.

NicoChamps is a smoking cessation treatment with a mechanism where varenicline partially binds to nicotinic receptors in the brain to relieve smoking cravings and withdrawal symptoms.

‘NicoChamps’, launched in July 2020, was the only product that met the FDA standard for release at the time of the detection of excessive impurities (N-Nitroso-valenicline, NNV) in varenicline in September last year. It has an unrivaled market. market share.

According to IMS DATA, a pharmaceutical market research institute, ‘Nico Champs’ achieved cumulative sales of 10 billion won in Korea after the detection of impurities in varenicline, and about 81% of varenicline products in the smoking cessation treatment market recorded for the past year. .

The smoking cessation treatment support market has grown since the government’s smoking cessation treatment support policy began in 2015. The smoking cessation treatment support policy is a policy that fully support the cost of the drug for participants who complete all 12-week smoking cessation treatment programs.

Applications can be made at hospitals, clinics and smoking cessation clinics at public health centres, and smokers who have failed to quit smoking can receive medical services and tailored prescriptions.

As the COVID-19 pandemic slows and some smoking cessation clinics reopen, the number of patients participating in smoking cessation is steadily increasing, and they are enjoying the benefits of prescriptions for cessation treatment smoking. In September last year, the Ministry of Food and Drug Safety published the results of the NNV detection test of varenicline and announced that only products with an NNV of 185 ng / day or less could be prescribed for the time being, so NicoChamps is expected. to continue to dominate.

Kim Min-ho, CEO of Jeil Pharm, Nico Champs, said, “As the sales volume of Nico Champs increases, it is meaningful that the company not only succeeds in quitting smoking but also contributes to creating a healthy society .” He said.